Search

FDA Acknowledgment Letter to Lusonix Group

The FDA has posted an acknowledgment letter sent to Lusonix Group regarding a submission. The letter, authored by CDRH, confirms receipt of materials but provides no further details on the nature of the submission or any regulatory actions.

Luxsonix Group Variance Approval Letter

The FDA has issued a variance approval letter to Luxsonix Group. This notice pertains to a specific variance granted by the Center for Devices and Radiological Health (CDRH).

FDA CDRH Variance Approval Letter for Photon GFX

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Photon GFX. This notice indicates a specific approval for a medical device variance, though no further details or documents are available for review.

FDA Complaint Document

The FDA has posted a complaint document to the Regs.gov portal on March 17, 2026. The document is available for public viewing and download via the provided link.

Harmony Foods Multivitamin Gummies - FDA Docket

The FDA has opened Docket FDA-2025-S-0024 concerning Harmony Foods Multivitamin Gummies. An attachment from Harmony Foods LLC provides details on their Meijer Wellness Women's Multivitamin Gummies.

FDA Complaint Document

The FDA has posted a complaint document to the Regs.gov portal. The document, authored by CTP, is available for review and download. No specific details regarding the nature of the complaint or its implications are provided in the metadata.

FDA Complaint Document

The FDA has posted a complaint document related to FDA-2026-H-2575-0001. The document was made available on March 17, 2026, and is authored by CTP.

FDA - Swanson Health Products Menopause Support

The FDA has posted a document related to Swanson Health Products' Menopause Support supplement. The document, identified as FDA-2025-S-0024-1968, is available for review on the Regs.gov platform. No specific regulatory action or compliance requirement is detailed in the provided information.

FDA Complaint Consultation

The FDA has posted a complaint for public comment, with the comment period closing on March 17, 2026. This action allows stakeholders to provide input on the complaint's content.

FDA - Vitanica BreastBlend Claim Review

The FDA has received a submission regarding Vitanica's BreastBlend product, which claims to support healthy breast tissue. This notice indicates the FDA is aware of the product and its claims, but no specific regulatory action or enforcement is detailed in the provided information.